Enrollment Milestone Achieved in MyPEAK™-1 and RIDGE™-1 Clinical Trials
August 6, 2025 - 23:19
Tenaya Therapeutics has announced significant progress in its clinical trials, marking a pivotal moment for its innovative therapies targeting specific heart conditions. The enrollment process for Cohorts 1 and 2 of the MyPEAK™-1 Phase 1b/2 trial of TN-201, aimed at treating MYBPC3-associated hypertrophic cardiomyopathy (HCM), has been successfully completed. This achievement has been bolstered by a positive safety review from the Data Safety Monitoring Board (DSMB), which has now allowed the company to proceed with the enrollment of expansion cohorts.
In addition, the RIDGE™-1 Phase 1b trial of TN-401 has also made strides, with Cohort 1 fully enrolled and the first patient with PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC) dosed in Cohort 2. This advancement follows the DSMB's recommendation to escalate dosing and expand the trial.
Tenaya Therapeutics is set to provide data readouts from both clinical programs in the fourth quarter of 2025, with a cash runway projected to extend into the second half of 2026, ensuring continued development of these promising therapies.
MORE NEWS
April 7, 2026 - 00:24
Making Cents: Financial expert shares everyday habit to rethinkA leading financial expert is urging consumers to critically examine one of their most routine money habits: the use of digital payment apps and cards for daily, small purchases. While convenient,...
April 6, 2026 - 02:35
A Generational Investment Opportunity: 3 AI Stocks I'm Buying NowThe recent market volatility has created a compelling entry point for investors looking to build a position in the transformative field of artificial intelligence. Several industry-leading...
April 5, 2026 - 01:23
Isa savers under 65 have ‘last chance’ in the new 2026-27 tax yearThe approaching 2026-27 tax year represents a pivotal deadline for many UK savers. Individuals under the age of 65 are being alerted to a final chance to fully utilise the current annual Cash ISA...
April 4, 2026 - 17:14
Copper-Aluminum Divergence Unveils The Complex Iran War ImpactFour weeks into the ongoing Middle East conflict, a significant divergence has emerged between two key industrial metals: copper and aluminum. While both are sensitive to global economic sentiment,...